AU2024302819A1 - Zinc finger protein, zinc finger nuclease, vector, and genome editing method using said substances - Google Patents

Zinc finger protein, zinc finger nuclease, vector, and genome editing method using said substances

Info

Publication number
AU2024302819A1
AU2024302819A1 AU2024302819A AU2024302819A AU2024302819A1 AU 2024302819 A1 AU2024302819 A1 AU 2024302819A1 AU 2024302819 A AU2024302819 A AU 2024302819A AU 2024302819 A AU2024302819 A AU 2024302819A AU 2024302819 A1 AU2024302819 A1 AU 2024302819A1
Authority
AU
Australia
Prior art keywords
seq
vector
zfp
nls
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2024302819A
Other languages
English (en)
Inventor
Aiko ISHIMARU
Wataru Nomura
Akishi Onishi
Tetsushi Sakuma
Takashi Yamamoto
Kazushi Yasuda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vcgt Inc
Hiroshima University NUC
Original Assignee
Vcgt Inc
Hiroshima University NUC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vcgt Inc, Hiroshima University NUC filed Critical Vcgt Inc
Publication of AU2024302819A1 publication Critical patent/AU2024302819A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/09—Fusion polypeptide containing a localisation/targetting motif containing a nuclear localisation signal
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/80—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor
    • C07K2319/81—Fusion polypeptide containing a DNA binding domain, e.g. Lacl or Tet-repressor containing a Zn-finger domain for DNA binding

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
AU2024302819A 2023-06-16 2024-06-14 Zinc finger protein, zinc finger nuclease, vector, and genome editing method using said substances Pending AU2024302819A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2023098848 2023-06-16
JP2023-098848 2023-06-16
PCT/JP2024/021599 WO2024257843A1 (ja) 2023-06-16 2024-06-14 ジンクフィンガータンパク質、ジンクフィンガーヌクレアーゼ、ベクター並びにこれらを用いたゲノム編集方法

Publications (1)

Publication Number Publication Date
AU2024302819A1 true AU2024302819A1 (en) 2026-01-22

Family

ID=93852226

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2024302819A Pending AU2024302819A1 (en) 2023-06-16 2024-06-14 Zinc finger protein, zinc finger nuclease, vector, and genome editing method using said substances

Country Status (5)

Country Link
EP (1) EP4729547A1 (https=)
JP (1) JPWO2024257843A1 (https=)
CN (1) CN121127501A (https=)
AU (1) AU2024302819A1 (https=)
WO (1) WO2024257843A1 (https=)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019060631A1 (en) * 2017-09-20 2019-03-28 Helix Nanotechnologies, Inc. EXPRESSION SYSTEMS THAT FACILITATE THE DELIVERY OF NUCLEIC ACIDS AND METHODS OF USE
MX2021002250A (es) 2018-08-27 2021-05-27 Univ Hiroshima Dominio de nucleasa novedoso y uso del mismo.
EP3980533A1 (en) * 2019-06-07 2022-04-13 Scribe Therapeutics Inc. Engineered casx systems
EP4405490A2 (en) * 2021-09-23 2024-07-31 Scribe Therapeutics Inc. Self-inactivating vectors for gene editing
CN115716880A (zh) * 2022-12-07 2023-02-28 云舟生物科技(广州)股份有限公司 一种核定位荧光蛋白及其应用

Also Published As

Publication number Publication date
WO2024257843A1 (ja) 2024-12-19
CN121127501A (zh) 2025-12-12
EP4729547A1 (en) 2026-04-22
JPWO2024257843A1 (https=) 2024-12-19

Similar Documents

Publication Publication Date Title
JP7365374B2 (ja) ヌクレアーゼ介在性遺伝子発現調節
US12037611B2 (en) Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods
EP3289080B1 (en) Gene therapy for autosomal dominant diseases
JP7733865B2 (ja) 強化されたｈＡＴファミリーのトランスポゾンが介在する遺伝子導入ならびに関連する組成物、システム、及び方法
AU2018309716B2 (en) Cas-transgenic mouse embryonic stem cells and mice and uses thereof
US12285495B2 (en) Genome editing methods and constructs
KR20200132849A (ko) CRISPR/Cas 시스템을 사용한 동물에서의 전사 조절
US20220280569A1 (en) ENHANCED hAT FAMILY TRANSPOSON-MEDIATED GENE TRANSFER AND ASSOCIATED COMPOSITIONS, SYSTEMS, AND METHODS
JP2025501473A (ja) エンジニアリングされたＣａｓ１２ｂエフェクタータンパク質及びその使用方法
WO2024240138A1 (zh) 基于perv逆转录酶的先导编辑系统
AU2024302819A1 (en) Zinc finger protein, zinc finger nuclease, vector, and genome editing method using said substances
US12611469B2 (en) Promoter specific for non-pigmented ciliary epithelial cells
KR20230125806A (ko) 선천성 근이영양증의 치료를 위한 치료용 lama2 페이로드
RU2833486C1 (ru) Стратегии crispr и aav для терапии х-сцепленного ювенильного ретиношизиса
US20230272355A1 (en) ENHANCED hAT FAMILY MEMBER SPIN TRANSPOSON-MEDIATED GENE TRANSFER AND ASSOCIATED COMPOSITIONS, SYSTEMS, AND METHODS
HK40075787A (en) Gene therapy for autosomal dominant diseases
WO2021207493A2 (en) Production of human cells, tissues, and organs in a growth factor receptor-deficient animal host
Chalberg Jr PhiC31 integrase for non-viral gene therapy in the mammalian retina
WO2010028245A2 (en) Altered phic31 integrases having improved efficiency and specificity and methods of using same
HK1251615B (en) Gene therapy for autosomal dominant diseases